Hospital
Riverside Healthcare System, L.P.
Riverside Healthcare System, L.P. was paid $4.92M by Medicaid between Jan 2018 and Nov 2024, across 92 billing codes. Its largest line is 0450, Emergency room services — 21% of everything it billed.
33Billing provider infoRIVERSIDE HEALTHCARE SYSTEM, L.P.
RIVERSIDE, CA 92501
RIVERSIDE, CA 92501
33aNPI1114971660assigned 05/20/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$4.92M
24GClaims161,886
24DCodes billed92
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other General Acute Care Hospital providers in California
Rank by total paid#227 of 410
Median peer was paid$6.90M
This provider vs. median0.7×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 34,272 | $920K | |
| 2019 | 27,788 | $1.87M | |
| 2020 | 20,855 | $442K | |
| 2021 | 23,937 | $542K | |
| 2022 | 27,037 | $581K | |
| 2023 | 19,793 | $414K | |
| 2024incomplete | 8,204 | $152K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 0450 | Emergency room services | 21% | 17,359 | 15,502 | $1.04M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 11% | 1,951 | 1,798 | $561K |
| 99499 | 11% | 9,576 | 8,331 | $557K | |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 8.1% | 2,113 | 1,950 | $399K |
| 70450 | Computed tomography, head or brain; without contrast material | 5.7% | 2,113 | 1,939 | $283K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 4.8% | 1,594 | 1,490 | $238K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 4.1% | 4,188 | 3,693 | $202K |
| 80053 | Comprehensive metabolic panel | 3.1% | 12,854 | 10,635 | $151K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 2.9% | 7,204 | 6,355 | $144K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 2.8% | 354 | 303 | $140K |
| 0272 | 2.2% | 1,089 | 945 | $111K | |
| 96361 | Intravenous infusion, hydration; each additional hour | 2.1% | 2,863 | 2,280 | $104K |
80 more codes
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.7% | 3,502 | $83K |
| 85027 | 1.7% | 16,162 | $82K | |
| 71045 | Radiologic examination, chest; single view | 1.6% | 6,119 | $78K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1.5% | 1,119 | $76K |
| 83690 | 1.1% | 8,125 | $55K | |
| 96375 | Therapeutic injection; each additional sequential IV push | 1.1% | 2,009 | $52K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1.0% | 103 | $52K |
| 84484 | 1.0% | 6,061 | $50K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 577 | $37K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 506 | $36K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 261 | $34K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 3,114 | $31K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 3,023 | $29K |
| 84703 | <1% | 3,127 | $26K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 38 | $22K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 379 | $20K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 532 | $19K |
| 83880 | <1% | 1,000 | $18K | |
| J3490 | Unclassified drugs | <1% | 10,180 | $12K |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 2,257 | $11K |
| 0250 | <1% | 5,185 | $10K | |
| 76830 | Ultrasound, transvaginal | <1% | 137 | $10K |
| A0429 | Emergency ambulance ride, basic life support | <1% | 314 | $10K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 3,204 | $10K |
| 81001 | <1% | 3,387 | $9K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 305 | $8K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 490 | $8K |
| 85610 | <1% | 2,123 | $8K | |
| G0378 | Hospital observation service, per hour | <1% | 50 | $8K |
| 86850 | <1% | 604 | $7K | |
| 85730 | <1% | 1,414 | $7K | |
| 0270 | <1% | 2,003 | $6K | |
| 86901 | <1% | 1,592 | $5K | |
| 86900 | <1% | 1,588 | $5K | |
| 84702 | <1% | 324 | $4K | |
| 0259 | <1% | 124 | $4K | |
| 87040 | <1% | 417 | $4K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 74 | $4K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 18 | $3K |
| 73630 | <1% | 120 | $3K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 862 | $3K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 685 | $3K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 67 | $3K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 37 | $3K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,397 | $3K |
| 83605 | <1% | 377 | $2K | |
| 73562 | <1% | 137 | $2K | |
| 73610 | <1% | 94 | $2K | |
| 87631 | <1% | 34 | $2K | |
| 76801 | <1% | 28 | $2K | |
| 96376 | <1% | 147 | $1K | |
| 83735 | <1% | 661 | $1K | |
| 82150 | <1% | 70 | $1K | |
| 73110 | <1% | 14 | $1K | |
| 73130 | <1% | 54 | $919.11 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 267 | $801.69 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 75 | $629.26 |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 74 | $522.60 |
| 93971 | <1% | 12 | $511.52 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 158 | $486.82 |
| 73030 | <1% | 26 | $371.08 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 84 | $338.46 |
| 87486 | <1% | 18 | $331.68 | |
| 87581 | <1% | 18 | $331.68 | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 18 | $272.53 |
| 80061 | Lipid panel | <1% | 60 | $269.86 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 16 | $247.39 |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 70 | $203.92 |
| 86140 | <1% | 35 | $127.44 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 55 | $123.80 |
| 84439 | <1% | 17 | $76.22 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 35 | $36.50 |
| 84100 | <1% | 41 | $31.74 | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 40 | $30.34 |
| A9270 | Non-covered item or service | <1% | 1,006 | $2.68 |
| 0301 | 0% | 48 | $0.00 | |
| 0636 | 0% | 28 | $0.00 | |
| 0305 | 0% | 43 | $0.00 | |
| 0302 | 0% | 14 | $0.00 | |
| G1003 | Clinical decision support mechanism medicalis, as defined by the medicare appropriate use criteria program | 0% | 39 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLACAZE, ASHLEY (CFO)
| Provider | Location | Paid |
|---|---|---|
| Riverside Healthcare System, L.P. | Riverside, CA | $65.58M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.